Your browser doesn't support javascript.
loading
Practice patterns of prenatal and perinatal testing in Canadian cytogenetics laboratories.
Ashfield, Tamara; McCready, Elizabeth; Shago, Mary; Wang, Hong; Sinclair-Bourque, Elizabeth; Cappa, Eva; Piche Marolt, Amanda; Chun, Kathy.
Afiliação
  • Ashfield T; Institute for Quality Management in Healthcare, Toronto, Canada.
  • McCready E; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada.
  • Shago M; Hamilton Regional Laboratory Medicine Program, Hamilton Health Sciences, Hamilton, Canada.
  • Wang H; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Canada.
  • Sinclair-Bourque E; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
  • Cappa E; Genetics Program, North York General Hospital, Toronto, Canada.
  • Piche Marolt A; Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa, Canada.
  • Chun K; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital - Joseph & Wolf Lebovic Health Complex, Toronto, Canada.
Prenat Diagn ; 41(7): 843-854, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33882154
OBJECTIVE: To survey patterns of practice in Canadian cytogenetics laboratories and evaluate whether newer technologies have influenced testing algorithms for the detection of common aneuploidies and other genomic imbalances in the prenatal and perinatal settings. METHODS: Cytogenetics laboratories across Canada were invited to participate in two patterns-of-practice surveys: one in 2016 and one in 2019. They were asked to identify the prenatal and perinatal specimen types tested at their facility and which testing methods were used for initial testing and for follow-up. RESULTS: All clinical laboratories performing prenatal testing offer rapid aneuploidy detection (RAD). Most laboratories also offer microarray analysis. A positive result is either followed up by karyotyping or no further testing is performed. For prenatal samples, a negative result may be followed up by microarray or karyotyping and is dependent on the reason for referral. For perinatal samples, availability of microarray to follow up a negative result is increasing. CONCLUSIONS: Since 2016, the availability of RAD as a first-line test in Canadian cytogenetics laboratories remains consistent, while microarray has become the preferred follow-up testing method over traditional karyotyping following a normal RAD result. Despite a universal healthcare system, disparities in prenatal and perinatal cytogenetic testing algorithms are apparent.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Padrões de Prática Médica / Teste Pré-Natal não Invasivo Tipo de estudo: Diagnostic_studies Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Padrões de Prática Médica / Teste Pré-Natal não Invasivo Tipo de estudo: Diagnostic_studies Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article